NCT04281511View on ClinicalTrials.gov

A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy

CompletedOBSERVATIONAL
Enrollment

238

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Pancreatic Cancer
Trial Locations (1)

10408

NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT04281511 - A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter